Industry Projects | Projects by Region | Projects by Category | Archived Projects | Project Gallery
 

AMR101 – Omega-3-Based Treatment for Hypertriglyceridaemia, United Kingdom



High levels of triglycerides in the body are the cause of hypertriglyceridaemia, which can lead to cardiovascular diseases and other disorders.


Back to Project Details



Related Projects

Ariflo (Cilomilast) - Oral PDE-IV Inhibitor for
Ariflo (cilomilast) is an oral selective phosphodiesterase (PDE) IV...

Capravirine - Anti-Retroviral Drug
Developed by Pfizer Global Research and Development, capravirine is...

Prexige - COX-2 Inhibitor
Prexige (lumiracoxib) is an innovative COX-2 inhibitor developed by...

Erbitux (Cetuximab)
Erbitux is a chimaeric monoclonal antibody (MAb) that is specific for...

Tarceva - Small Molecule
Tarceva (erlotinib) is an oral anti-cancer drug developed by...

See all projects


Contact us
Advertise with us
Terms and conditions
Privacy
Links
Newsletter sign up
Online magazine sign up

drugdevelopment-technology.com is a product of Net Resources International. Copyright 2011 Net Resources International, a trading division of SPG Media Limited.